Immatics N.V. Statistics
NASDAQ: IMTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
5.77-0.18 (-3.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Immatics N.V. by the numbers
Immatics N.V. has a market capitalization of $878.6 million based on 152.27M shares outstanding. With trailing EPS of $-1.95, Immatics N.V. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.1% below its 50-day average and 38.2% below its 200-day average.
Average daily trading volume is 962.74K shares, or about $5.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMTX valuation vs. peer median
| Metric | IMTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $878.58M | $785.76M | +12% |
| Avg. volume | 962.74K | 842.23K | +14% |
Peer median across 8 companies: ODTX, BBTX, PRME, MGTX, INBX, GLUE, AURA, SLDB.
Valuation
- Market cap
- $878.58M
- EPS (TTM)
- $-1.95
- Shares outstanding
- 152.27M
Price and trading
- Previous close
- 5.95
- Open
- 5.86
- Day range
- 5.72 – 5.95
- 52-week range
- 5.72 – 12.41
- 52-week change
- -43.43%
- Beta
- —
- Volume
- 746.64K
- Average volume
- 962.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 878.58M
- Forward Pe
- -2.88
- Eps
- -1.95
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.41
- Week52 Low
- 5.72
- Avg Volume
- 962.74K
- Shares Outstanding
- 152.27M
- Ma50
- 7.40
- Ma200
- 9.34
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -53.51%
- Pct From52w Low
- 0.96%